Clifford Stephan

机构：The University of Texas MD Anderson Cancer Center, Texas A&M Health Science Center, Translational Research in Oncology, High Throughput Biology (United States), The University of Texas Health Science Center, Texas A&M University, The University of Texas Health Science Center at Houston

发表论文 246 篇 · 总被引 3027 次 · h-index 28

代表论文

• Personalized targeting of BCL2 family proteins overcomes acquired resistance to BRAF-MEK inhibitors in preclinical melanoma (2026 · Nature Communications · 被引 1)
• Acquired Resistance to the PRMT5 Inhibitor Confers Collateral Sensitivity to MEK Inhibition in MTAP-Null Non-Small Cell Lung Cancer (2026 · Biomolecules)
• Supplementary Table S1 from Drug Screening of Sarcoma Cells: Finding Shared Sensitivities (2026)
• Supplemental Figure S3 from Drug Screening of Sarcoma Cells: Finding Shared Sensitivities (2026)
• Supplemental Figure S1 from Drug Screening of Sarcoma Cells: Finding Shared Sensitivities (2026)
• Supplemental Figure S2 from Drug Screening of Sarcoma Cells: Finding Shared Sensitivities (2026)